0
2018
Thyroid Gland Disorder Treatment Market

Thyroid Gland Disorder Treatment Market

by Disease Type (Hyperthyroidism and Hypothyroidism), Drug Type (Levothyroxine, Liothyronine, Propylthiouracil, Imidazole-based Compound, and Others), Route of Administration (Oral, Intravenous, and Others), and Distribution/Sales Channel (Wholesaler/Distributor, Retailer, Mail-order Pharmacy, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2025
Update Available On-Demand

Report Code: A03420
Pages: 243
Jun 2018 | 13703 Views
Author(s) : Tenzin K
Tables: 145
Charts: 44
  • Formats*:

  • Single User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • It comes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Thyroid Gland Disorder Treatment Market

Request Now !

Thyroid Gland Disorder Treatment Market Overview:

Thyroid Gland Disorder Treatment Market is an endocrine gland that stimulates hormones, which help regulate the metabolism of the body. When the thyroid gland does not produce enough thyroid hormones (hypothyroidism) or too much hormone (hyperthyroidism), the metabolism and functioning of the body is disrupted. The lack of iodine in the body is a major factor that leads to thyroid disorder. It has been observed that more than 2 billion people are estimated to be at the risk of iodine deficiency worldwide, among which the developing countries have the highest number of undiagnosed patients. The global thyroid gland disorder market was valued at $2,057 million in 2017, and is estimated to reach $2,771 million by 2025 at a CAGR of 3.8% from 2018 to 2025.

The major factors that drive the growth of the market include increase in the incidence of thyroid gland disorder, rise in the number of disease awareness programs especially in the developing countries, and development of effective combination drug therapies to treat thyroid gland disorder. However, side effects of the drugs and stringent government regulations hamper the market growth. Moreover, availability of large pool of undiagnosed patients due to asymptomatic nature of thyroid disorders help open new avenues for the market growth during the forecast period.

Disease type segment review

Based on the disease type, the market is bifurcated into hypothyroidism and hyperthyroidism. The hypothyroidism segment dominates the market, owing to the high prevalence of iodine deficiency population worldwide, and is the most commonly occurring thyroid disorder.

by disease type

Route of administration segment review

Based on route of administration, the market is classified into oral, intravenous, and others. Oral route of administration is the largest contributor toward the market growth as most of the medications available in the market are in the form of tablets or pills and can be easily administered by patients on daily basis.
 

by route of administration


Key geographical segment

As per region, the thyroid gland disorder treatment market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America accounted for the largest market share in 2017, and is expected to retain its dominance throughout the forecast period.
 

by geography

The key players operating in the global thyroid gland disorder treatment market include AbbVie Inc., Pfizer Inc., Merck & Co., Inc., Lannett Company, Inc., Allergan plc, Mylan N.V., GlaxoSmithKline plc, Novartis AG, RLC LABS, Inc., and Abbott Laboratories.

Other prominent players in the value chain include Takeda Pharmaceutical Company Limited, Aspen, Amgen Inc., Endo International plc, Acella Pharmaceuticals, LLC, and Gemini Laboratories, LLC.

Key Benefits

  • This report entails a detailed quantitative analysis of the current market trends from 2017 to 2025 to identify the prevailing opportunities.
  • Market estimations are based on comprehensive analysis of the key developments in the industry.
  • The global market is comprehensively analyzed with respect to disease type, drug type, route of administration, distribution channels, and region.
  • In-depth analysis based on region assists to understand the regional market to assist in strategic business planning.
  • The development strategies adopted by key manufacturers are enlisted to understand the competitive scenario of the market.

Thyroid Gland Disorder Treatment Market Report Highlights

Aspects Details
BY DISEASE TYPE
  • Hypothyroidism
  • Hyperthyroidism
BY DRUG TYPE
  • Levothyroxine
  • Liothyronine
  • Propylthiouracil
  • Imidazole-based compounds
  • Others
BY ROUTE OF ADMINISTRATION
  • Oral
  • Intravenous route
  • Others
BY DISTRIBUTION CHANNEL
  • Wholesaler/Distributor Retailer Mail-order Pharmacy Others
  • Retailer
  • Mail-Order Pharmacy
  • Others
BY GEOGRAPHY
  • North America
    • U.S
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA
Key Market Players Abbott Laboratories, AbbVie Inc, Allergan Plc, GlaxoSmithKline plc, Lannett Company, Inc, Merck & Co. Inc, Mylan N.V, Novartis AG, Pfizer Inc, RLC LABS, Inc
 

Loading Table Of Content...


 
 

Thyroid hormones play an important role in the growth, reproduction, neuronal development, and regulation of energy metabolism. Hypothyroidism and hyperthyroidism caused due to lack or overproduction of thyroid hormone can cause potentially devastating health consequences. Increase in the incidence of thyroid gland disorder and rise in the number of disease awareness programs especially in the developing countries majorly drive the growth of the thyroid gland disorder treatment market.

Patients require medication to either boost the production of thyroid hormones or block the over production of thyroid hormones. Levothyroxine accounts for the largest market share among all these drug types, mainly due to the availability of these drugs in various brand forms. In addition, these drugs can easily be absorbed by the patient and help regulate thyroid hormone.

The use of thyroid gland disorder treatment is highest in North America, particularly in the U.S., owing to highest prevalence rate for thyroid disorders, large number of diagnosed patients as compared to other regions, and favorable reimbursement policies. Although the use of thyroid gland disorder treatment in Asia-Pacific and LAMEA is low, the adoption rate is expected to increase due to the increase in awareness about thyroid conditions and the availability of large number of undiagnosed patients in populace countries such as India and China.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Request Free Sample

Purchase Full Report of
Thyroid Gland Disorder Treatment Market

Start reading instantly.
This Report and over 19,300+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,456
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
    (Jun 2019 - Jun 2020)
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Jun 2019 - Jun 2020)
  • Single User
  • $5,769
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Jun 2019 - Jun 2020)
  • Five Users
  • $6,450
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Jun 2019 - Jun 2020)
  • Enterprise
    License/PDF

  • $10,995
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Jun 2019 - Jun 2020)
  • Library
    Membership

  • $ 999
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers